Source: European Urology Supplements. Conference titles: Annual Congress of the European Association of Urology. Unidade: FM
Subjects: MULHERES, HOMENS, CICLOSPORINAS, BEXIGA (PATOLOGIA;TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHADE, J. et al. 5-year follow-up of patients with refractory interstitial cystitis treated with cyclosporine A: A prospective single-institution study. European Urology Supplements. Amsterdan: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1569-9056(14)60456-5. Acesso em: 08 out. 2024. , 2014APA
Chade, J., Chade, D., Lucon, A. M., Bruschini, H., & Srougi, M. (2014). 5-year follow-up of patients with refractory interstitial cystitis treated with cyclosporine A: A prospective single-institution study. European Urology Supplements. Amsterdan: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S1569-9056(14)60456-5NLM
Chade J, Chade D, Lucon AM, Bruschini H, Srougi M. 5-year follow-up of patients with refractory interstitial cystitis treated with cyclosporine A: A prospective single-institution study [Internet]. European Urology Supplements. 2014 ; 13( 1): e462.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/S1569-9056(14)60456-5Vancouver
Chade J, Chade D, Lucon AM, Bruschini H, Srougi M. 5-year follow-up of patients with refractory interstitial cystitis treated with cyclosporine A: A prospective single-institution study [Internet]. European Urology Supplements. 2014 ; 13( 1): e462.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/S1569-9056(14)60456-5
